The Procter & Gamble Company (NYSE:PG - Get Free Report)'s stock price traded down 0.7% on Monday . The company traded as low as $166.71 and last traded at $166.88. 952,649 shares were traded during mid-day trading, a decline of 86% from the average session volume of 6,730,623 shares. The stock had previously closed at $168.06.
Wall Street Analyst Weigh In
PG has been the subject of several research reports. Evercore ISI increased their price target on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an "outperform" rating in a research note on Monday, October 21st. Wells Fargo & Company lifted their target price on shares of Procter & Gamble from $188.00 to $190.00 and gave the company an "overweight" rating in a report on Friday, November 22nd. Hsbc Global Res upgraded Procter & Gamble to a "strong-buy" rating in a research note on Friday, October 4th. Royal Bank of Canada reiterated a "sector perform" rating and set a $164.00 price objective on shares of Procter & Gamble in a research note on Monday, October 21st. Finally, DA Davidson raised Procter & Gamble from a "neutral" rating to a "buy" rating and increased their target price for the stock from $160.00 to $209.00 in a research note on Monday, November 25th. Eight investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $180.45.
Get Our Latest Stock Report on Procter & Gamble
Procter & Gamble Stock Performance
The company has a market cap of $395.91 billion, a P/E ratio of 28.98, a P/E/G ratio of 3.70 and a beta of 0.44. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The business has a fifty day simple moving average of $170.80 and a two-hundred day simple moving average of $169.81.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The company had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. During the same quarter last year, the firm posted $1.83 earnings per share. The firm's revenue was down .6% compared to the same quarter last year. On average, sell-side analysts anticipate that The Procter & Gamble Company will post 6.94 EPS for the current year.
Procter & Gamble Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were given a dividend of $1.0065 per share. The ex-dividend date was Friday, October 18th. This represents a $4.03 annualized dividend and a yield of 2.39%. Procter & Gamble's dividend payout ratio (DPR) is presently 69.31%.
Insiders Place Their Bets
In related news, CEO Gary A. Coombe sold 47,847 shares of the company's stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total value of $8,604,804.48. Following the completion of the transaction, the chief executive officer now owns 39,977 shares of the company's stock, valued at approximately $7,189,463.68. This represents a 54.48 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Balaji Purushothaman sold 12,800 shares of the firm's stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of $168.99, for a total value of $2,163,072.00. Following the sale, the insider now directly owns 11,566 shares in the company, valued at approximately $1,954,538.34. This represents a 52.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 83,080 shares of company stock worth $14,629,038 over the last quarter. 0.18% of the stock is currently owned by corporate insiders.
Institutional Trading of Procter & Gamble
Institutional investors have recently made changes to their positions in the business. Itau Unibanco Holding S.A. purchased a new stake in Procter & Gamble in the 2nd quarter worth $28,000. Fairway Wealth LLC bought a new position in Procter & Gamble during the second quarter valued at approximately $29,000. RPg Family Wealth Advisory LLC purchased a new position in Procter & Gamble during the 3rd quarter valued at approximately $33,000. Quest Partners LLC bought a new stake in Procter & Gamble in the 2nd quarter worth approximately $36,000. Finally, Fairfield Financial Advisors LTD purchased a new stake in shares of Procter & Gamble during the 2nd quarter worth approximately $44,000. Hedge funds and other institutional investors own 65.77% of the company's stock.
About Procter & Gamble
(
Get Free Report)
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
See Also
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.